How Can We Assess the Safety of Silver Nanoparticles?
Comprehensive risk assessment of AgNPs involves in vitro and in vivo studies, as well as computational models. Key approaches include:
Toxicokinetics: Understanding how AgNPs are absorbed, distributed, metabolized, and excreted in the body. Dose-Response Studies: Determining the relationship between the dose of AgNPs and the observed toxic effects. Long-term Studies: Evaluating the chronic effects of AgNP exposure over extended periods.
